WO2009144314A3 - Coating means for coating a surface of a medical implant - Google Patents

Coating means for coating a surface of a medical implant Download PDF

Info

Publication number
WO2009144314A3
WO2009144314A3 PCT/EP2009/056667 EP2009056667W WO2009144314A3 WO 2009144314 A3 WO2009144314 A3 WO 2009144314A3 EP 2009056667 W EP2009056667 W EP 2009056667W WO 2009144314 A3 WO2009144314 A3 WO 2009144314A3
Authority
WO
WIPO (PCT)
Prior art keywords
coating
medical implant
component
pharmacologically effective
coating means
Prior art date
Application number
PCT/EP2009/056667
Other languages
German (de)
French (fr)
Other versions
WO2009144314A2 (en
Inventor
Peter Jentsch
Jakob Jilinski
Original Assignee
Peter Jentsch
Jakob Jilinski
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Peter Jentsch, Jakob Jilinski filed Critical Peter Jentsch
Priority to EP09753969A priority Critical patent/EP2300068A2/en
Publication of WO2009144314A2 publication Critical patent/WO2009144314A2/en
Publication of WO2009144314A3 publication Critical patent/WO2009144314A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/30—Inorganic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/34—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
    • A61L2300/104—Silver, e.g. silver sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/30—Compounds of undetermined constitution extracted from natural sources, e.g. Aloe Vera
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/606—Coatings

Abstract

The invention relates to a coating means for coating a surface of a medical implant (12), said means comprising at least one fungal component and/or a plant component as a pharmacologically effective component and at least one carrier means for absorbing the at least one pharmacologically effective component at the surface of the medical implant (12). The invention further comprises a method for coating a surface of a medical implant (12), a medical implant (12) and a coating chamber (10) for coating a medical implant (12).
PCT/EP2009/056667 2008-05-30 2009-05-29 Coating means for coating a surface of a medical implant WO2009144314A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP09753969A EP2300068A2 (en) 2008-05-30 2009-05-29 Coating means for coating a surface of a medical implant

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE200810026207 DE102008026207B4 (en) 2008-05-30 2008-05-30 Coating agent for coating a surface of a medical implant
DE102008026207.2 2008-05-30

Publications (2)

Publication Number Publication Date
WO2009144314A2 WO2009144314A2 (en) 2009-12-03
WO2009144314A3 true WO2009144314A3 (en) 2010-08-05

Family

ID=41051880

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2009/056667 WO2009144314A2 (en) 2008-05-30 2009-05-29 Coating means for coating a surface of a medical implant

Country Status (3)

Country Link
EP (1) EP2300068A2 (en)
DE (2) DE102008026207B4 (en)
WO (1) WO2009144314A2 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH688787A5 (en) * 1995-09-05 1998-03-31 Dieter Linsig Synergistic mixture of essential oils or essences
WO2001084936A1 (en) * 2000-05-05 2001-11-15 Scentsible Life Products, A Division Of Laid Back Designs Ltd. Antimicrobial composition formulated with essential oils
WO2002100456A1 (en) * 2001-06-13 2002-12-19 Boston Scientific Limited Using supercritical fluids to infuse therapeutic on a medical device
US20060068044A1 (en) * 2004-09-30 2006-03-30 Max Reynolds Antimicrobial compositions and applications therefore

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5624704A (en) * 1995-04-24 1997-04-29 Baylor College Of Medicine Antimicrobial impregnated catheters and other medical implants and method for impregnating catheters and other medical implants with an antimicrobial agent
DE69831938T2 (en) 1997-02-20 2006-07-06 Cook Inc., Bloomington COATED, IMPLANTABLE MEDICAL DEVICES
DE59913045D1 (en) * 1998-08-06 2006-04-06 Schierholz Joerg Michael MEDICAL DEVICES WITH RETARDED PHARMACOLOGICAL ACTIVITY AND METHOD FOR THE PRODUCTION THEREOF
WO2001095876A1 (en) * 2000-06-09 2001-12-20 Baylor College Of Medicine The combination of antimicrobial agents and bacterial interference to coat medical devices
WO2006036967A1 (en) * 2004-09-28 2006-04-06 Atrium Medical Corporation Solubilizing a drug for use in a coating
WO2006128634A1 (en) * 2005-05-28 2006-12-07 Hans-Ulrich Jabs Extract of olibanum (frankincense gum) in the form of nanoparticles, and use thereof
DE102005039126A1 (en) * 2005-08-18 2007-02-22 Lothar Sellin Device, useful for expanding lumen container, comprises paclitaxel and is coated with parylene C and/or aloe (aloe vera) extracts
DE102005044360A1 (en) * 2005-09-09 2007-03-15 Aesculap Ag & Co. Kg Medicinal technical-product, useful as e.g. temporary or durable implant and as biocides, comprises anti-microbial equipment from a complex material from metal-nanoparticle and macromolecules
DE102006038241A1 (en) * 2006-08-07 2008-02-14 Biotronik Vi Patent Ag Stent with a genisteinhaltigen coating or Kavitätenfüllung
GB0624340D0 (en) * 2006-12-06 2007-01-17 Nature Therapeutics Ltd Antimicrobial composition

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH688787A5 (en) * 1995-09-05 1998-03-31 Dieter Linsig Synergistic mixture of essential oils or essences
WO2001084936A1 (en) * 2000-05-05 2001-11-15 Scentsible Life Products, A Division Of Laid Back Designs Ltd. Antimicrobial composition formulated with essential oils
WO2002100456A1 (en) * 2001-06-13 2002-12-19 Boston Scientific Limited Using supercritical fluids to infuse therapeutic on a medical device
US20060068044A1 (en) * 2004-09-30 2006-03-30 Max Reynolds Antimicrobial compositions and applications therefore

Also Published As

Publication number Publication date
DE102008026207B4 (en) 2015-01-15
EP2300068A2 (en) 2011-03-30
DE102008026207A1 (en) 2009-12-03
DE202009007669U1 (en) 2009-09-03
WO2009144314A2 (en) 2009-12-03

Similar Documents

Publication Publication Date Title
WO2009111307A3 (en) Coating and coating method
WO2009065738A3 (en) Polyoxyalkylenamines for improved fragrance yield
WO2009048645A3 (en) Lipid coatings for implantable medical devices
WO2008046642A3 (en) Coated implant
MXPA05006900A (en) Method for treating plants or plant parts.
WO2005094440A3 (en) Nanofiber surface based capacitors
WO2005079756A3 (en) Combination of a nmda receptor antagonist and an anti-depressive drug mao-inhibitor or a gadph-inhibitor for the treatment of psychiatric conditions
WO2007075847A3 (en) Glucokinase activators
WO2009098223A3 (en) Plant health composition
WO2008112659A3 (en) Regulation of osteopontin
WO2006074406A3 (en) Biodegradable coating compositions including multiple layers
TW200736181A (en) Anti-reflective coatings
WO2007067398A3 (en) Solventless method for forming a coating
WO2009152356A3 (en) Compounds and compositions useful for the treatment of malaria
WO2006124713A3 (en) 4-biarylyl-1-phenylazetidin-2-ones
WO2009019477A3 (en) Coating
WO2011117758A3 (en) Implant for tissue repair
WO2008043812A3 (en) Method of film-coating articles
AU2006252649A8 (en) Method of treating a surface to protect the same
WO2009089263A3 (en) Novel compositions and methods of use
WO2008039362A3 (en) Methods for treating or preventing infestation
WO2008060795A3 (en) Antimicrobial articles and method of manufacture
WO2009098458A3 (en) Difluorobiphenylamide derivatives for the treatment of ocular hypertension
WO2011065832A3 (en) Improved formulations of phosphites
WO2010067987A2 (en) Novel 2,6-substituted-3-nitropyridine derivative, method for preparing same, and pharmaceutical composition including same

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09753969

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2009753969

Country of ref document: EP